LABORATORY CORPORATION OF AMERICA HOLDINGS

Autres langues Laboratory Corporation of America Holdings

Actions

LH

US50540R4092

Marché Fermé - Nyse Autres places de cotation 22:00:02 26/04/2024			Varia. 5j.	Varia. 1 janv.
198,4 ^USD	+0,03 %		-1,53 %	-12,71 %

26/04	LABORATORY CORPORATION OF AMERICA HOLDINGS : Opinion positive de Baird	ZM
26/04	LABORATORY CORPORATION OF AMERICA HOLDINGS : Barclays toujours positif	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated	25/04
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 Revenue $3.18B, vs. Street Est of $3.12B	25/04
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 EPS $3.68, vs. Street Est of $3.48	25/04
Labcorp: Q1 Earnings Snapshot	25/04
Laboratory Corporation of America Holdings Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Labcorp beats quarterly estimates on strong testing demand	25/04
Labcorp Announces 2024 First Quarter Results	25/04
North American Morning Briefing : More Tech -2-	25/04
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	25/04
Labcorp Announces Winning Bid for Select Assets of Invitae	25/04
Laboratory Corporation of America Holdings Announces Winning Bid for Select Assets of Invitae	25/04
Invitae Enters into Agreement with Labcorp for Sale of Business	25/04
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	24/04
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million.	24/04
Labcorp Introduces Test for Early Detection of Neurodegenerative Diseases	15/04
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	15/04
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	15/04
Labcorp Keeps Quarterly Dividend at $0.72 Per Share, Payable June 12 to Stockholders of Record May 28	11/04
Labcorp Declares Quarterly Dividend	11/04
Labcorp Declares Quarterly Dividend, Payable on June 12, 2024	11/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Laboratory Corporation of America Holdings

Actions

LH

US50540R4092

Autres langues

Filtres